Skip to content

Application of ultraviolet time-of-flight mass spectrometry in online monitoring of propofol concentration in exhalation

Application of ultraviolet time-of-flight mass spectrometry in online monitoring of propofol concentration in exhalation

Status
Active, not recruiting
Phases
Phase 4
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300074605
Enrollment
Unknown
Registered
2023-08-10
Start date
2023-08-15
Completion date
Unknown
Last updated
2023-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients who plan to undergo Elective surgery under general anesthesia and mechanical ventilation

Interventions

Case series:None

Sponsors

West China Hospital of Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1) The Elective surgery patients under general anesthesia and mechanical ventilation in West China Hospital of Sichuan University from June 2023 to June 2024 were selected; 2) Intraoperative intravenous anesthesia maintenance drugs include propofol; 3) 18 years = age<65 years; 4) 18.5 kg/m2 = Body Mass Index (BMI) = 30 kg/m2; 5) The American Society of Anesthesiologists (ASA) is classified as I-III;

Exclusion criteria

Exclusion criteria: (2) Exclusion criteria: 1) Patients with metabolic disorder and Endocrine disease such as diabetes and thyroid dysfunction before operation; 2) Preoperative patients with history of cardiovascular disease, cardiac dysfunction, arrhythmia and hypertension; 3) Patients with severe liver and kidney dysfunction before surgery; 4) Patients with acute or chronic lung disease or a history of lung surgery prior to surgery; 5) Patients with preoperative anemia (male: Hb<120g/L; female: Hb<110g/L); 6) Preoperative patients with Central nervous system disease and long-term use of psychotropic drugs; 7) Individuals with a history of excessive drinking and smoking; 8) Those who are allergic to soybeans and Milk allergy, and those who may be allergic to propofol; 9) Patients who have participated in other clinical trials in the past three months.

Design outcomes

Primary

MeasureTime frame
concentration of exhaled propofol ;

Secondary

MeasureTime frame
SBP,DBP,MAP;Bispectral index;heart rate;

Countries

China

Contacts

Public ContactZhang Wensheng

West China Hospital of Sichuan University

zhang_ws@scu.edu.cn+86 189 8060 1564

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026